![The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/cef7eacf-1f50-4531-9c5d-b839fae38f91/dom14496-fig-0001-m.jpg)
The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library
![The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/414ba3e0-5948-4dd5-a9ba-672073b1496d/dom14496-fig-0002-m.jpg)
The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library
![GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells | Science Advances GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells | Science Advances](https://www.science.org/cms/10.1126/sciadv.abf1948/asset/81121dd8-a105-47ab-b263-f658ea8714d0/assets/graphic/abf1948-f6.jpeg)
GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells | Science Advances
![Total Glucose-dependent Insulinotropic Peptide (GIP) ELISA, 27203 (RUO) | Human Total GIP (Gastric Inhibitory Polypeptide) Competitive Enzyme-linked Immune-sorbent Assay Kit IBL-America Total Glucose-dependent Insulinotropic Peptide (GIP) ELISA, 27203 (RUO) | Human Total GIP (Gastric Inhibitory Polypeptide) Competitive Enzyme-linked Immune-sorbent Assay Kit IBL-America](https://cdn11.bigcommerce.com/s-dpaty9ionu/images/stencil/1280x1280/products/5808/13955/pancreas2__49390.1635962302.png?c=2)
Total Glucose-dependent Insulinotropic Peptide (GIP) ELISA, 27203 (RUO) | Human Total GIP (Gastric Inhibitory Polypeptide) Competitive Enzyme-linked Immune-sorbent Assay Kit IBL-America
![GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism | American Journal of Physiology-Endocrinology and Metabolism GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism | American Journal of Physiology-Endocrinology and Metabolism](https://journals.physiology.org/cms/10.1152/ajpendo.00646.2020/asset/images/medium/e-00646-2020r01.png)
GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism | American Journal of Physiology-Endocrinology and Metabolism
![Biology | Free Full-Text | Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary ... Biology | Free Full-Text | Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary ...](https://pub.mdpi-res.com/biology/biology-11-00288/article_deploy/html/images/biology-11-00288-g001.png?1644579996)
Biology | Free Full-Text | Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary ...
![Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0079610711000812-gr2.jpg)
Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect
![GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist Induced Nausea and Emesis in Preclinical Models — Hayes Lab GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist Induced Nausea and Emesis in Preclinical Models — Hayes Lab](https://images.squarespace-cdn.com/content/v1/60df607bb8a6da20f8129dc4/1633110064575-ZJNJF1AZLH26R681LURW/F2.large-2+-+Tito+Borner.jpg)
GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist Induced Nausea and Emesis in Preclinical Models — Hayes Lab
![The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/4d065d23-33ad-42b7-bfbc-8a244219872f/dom14496-fig-0004-m.jpg)
The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library
Major physiological roles of GLP-1 and GIP. Tirzepatide is acting as an... | Download Scientific Diagram
![Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. | Semantic Scholar Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/852ca66060ffdba66beb14e27e19fbc2a63a970f/3-Figure2-1.png)
Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. | Semantic Scholar
![Life | Free Full-Text | Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment Life | Free Full-Text | Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment](https://pub.mdpi-res.com/life/life-12-00029/article_deploy/html/images/life-12-00029-g001.png?1640431486)
Life | Free Full-Text | Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment
![Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1 | Nature Reviews Endocrinology Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1 | Nature Reviews Endocrinology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41574-022-00783-3/MediaObjects/41574_2022_783_Fig1_HTML.png)
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1 | Nature Reviews Endocrinology
![The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology | Full Text The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12933-021-01412-5/MediaObjects/12933_2021_1412_Fig1_HTML.png)